Infertility
Infertility
QuickTime and a Microsoft Video Utility decompressor are needed to see this picture.
Definitions
Infertility
Inability to conceive after one year of unprotected intercourse (6 months for women over 35?)
Fertility
Ability to conceive
Fecundity
Ability to carry to delivery
Statistics
80% of couples will conceive within 1 year of unprotected intercourse ~86% will conceive within 2 years ~14-20% of US couples are infertile by definition (~3 million couples) Origin:
Female factor ~40% Male factor ~30% Combined ~30%
Etiologies
Sperm disorders 30.6% Anovulation/oligoovulation 30% Tubal disease 16% Unexplained 13.4% Cx factors 5.2% Peritoneal factors 4.8%
Associated Factors
PID Endometriosis Ovarian aging Spermatic varicocoele Toxins Previous abdominal surgery (adhesions) Cervical/uterine abnormalities Cervical/uterine surgery Fibroids
Overview of Evaluation
Female
Ovary Tube Corpus Cervix Peritoneum Sperm count and function Ejaculate characteristics, immunology Anatomic anomalies
Male
The Most Important Factor in the Evaluation of the Infertile Couple Is:
HISTORY
History-General
Both couples should be present Age Previous pregnancies by each partner Length of time without pregnancy Sexual history
Frequency and timing of intercourse Use of lubricants Impotence, anorgasmia, dyspareunia Contraceptive history
History-Male
History of pelvic infection Radiation, toxic exposures (include drugs) Mumps Testicular surgery/injury Excessive heat exposure (spermicidal)
History-Female
Previous female pelvic surgery PID Appendicitis IUD use Ectopic pregnancy history DES (?relation to infertility) Endometriosis
History-Female
Irregular menses, amenorrhea, detailed menstrual history Vasomotor symptoms Stress Weight changes Exercise Cervical and uterine surgery
Physical Exam-Male
Size of testicles Testicular descent Varicocoele Outflow abnormalities (hypospadias, etc)
Physical Exam-Female
Pelvic masses Uterosacral nodularity Abdominopelvic tenderness Uterine enlargement Thyroid exam Uterine mobility Cervical abnormalities
Ovary
Ovarian Function
Document ovulation:
BBT Luteal phase progesterone LH surge EMBx
If POF suspected, perform FSH TSH, PRL, adrenal functions if indicated The only convincing proof of ovulation is pregnancy
Ovarian Function
Three main types of dysfunction
Hypogonadotrophic, hypoestrogenic (central) Normogonadotrophic, normoestrogenic (e.g. PCOS) Hypergonadotrophic, hypoestrogenic (POF)
BBT
Cheap and easy, but
Inconsistent results Provides evidence after the fact (like the old story about the barn door and the horse) May delay timely diagnosis and treatment 98% of women will ovulate within 3 days of the nadir Biphasic profiles can also be seen with LUF syndrome
Urinary LH Kits
Very sensitive and accurate Positive test precedes ovulation by ~24 hours, so useful for timing intercourse Downside: price, obsession with timing of intercourse
Endometrial Biopsy
Invasive, but the only reliable way to diagnose LPD ??Is LPD a genuine disorder??? Pregnancy loss rate <1% Perform around 2 days before expected menstruation (= day 28 by definition) Lag of >2 days is consistent with LPD Must be done in two different cycles to confirm diagnosis of LPD
Fallopian Tubes
Tubal Function
Evaluate tubal patency whenever there is a history of PID, endometriosis or other adhesiogenic condition Kartageners syndrome can be associated with decreased tubal motility Tests
HSG Laparoscopy Falloposcopy (not widely available)
Hysterosalpingography (HSG)
Radiologic procedure requiring contrast Performed optimally in early proliferative phase (avoids pregnancy) Low risk of PID except if previous history of PID (give prophylactic doxycycline or consider laparoscopy) Oil-based contrast
Higher risk of anaphylaxis than H2O-based May be associated with fertility rates
Hysterosalpingography (HSG)
Can be uncomfortable Pregnancy test is advisable Can detect intrauterine and tubal disorders but not always definitive
Laparoscopy
Invasive; requires OR or office setting Can offer diagnosis and treatment in one sitting Not necessary in all patients Uses (examples):
Lysis of adhesions Diagnosis and excision of endometriosis Myomectomy Tubal reconstructive surgery
Falloposcopy
Hysteroscopic procedure with cannulation of the Fallopian tubes Can be useful for diagnosis of intraluminal pathology Promising technique but not yet widespread
Uterine Corpus
Corpus
Asherman Syndrome Fibroids, Uterine Anomalies
Ultrasound Hysteroscopy Laparoscopy
Diagnosis by HSG or hysteroscopy Usually s/p D+C, myomectomy, other intrauterine surgery Associated with hypo/amenorrhea, recurrent miscarriage Rarely associated with infertility Work-up:
Cervix
Cervical Function
Infection
Ureaplasma suspected
Stenosis
S/P LEEP, Cryosurgery, Cone biopsy (probably overstated)
Immunologic Factors
Sperm-mucus interaction
Cervical Function
Tests:
Culture for suspected pathogens Postcoital test (PK tests)
Scheduled around 1-2d before ovulation (increased estrogen effect) 480 of male abstinence before test No lubricants Evaluate 8-12h after coitus (overnight is ok!) Remove mucus from cervix (forceps, syringe)
Cervical Function
PK, continued (normal values in yellow)
Quantity (very subjective) Quality (spinnbarkeit) (>8 cm) Clarity (clear) Ferning (branched) Viscosity (thin) WBCs (~0)
Male factors
Peritoneum
Peritoneal Factors
Endometriosis
2x relative risk of infertility Diagnosis (and best treatment) by laparoscopy Can be familial; can occur in adolescents Etiology unknown but likely multiple ones
Retrograde menstruation Immunologic factors Genetics Bad karma
Male Factors
Male Factors
Serum T, FSH, PRL levels Semen analysis Testicular biopsy Sperm penetration assay (SPA)
Treatment Options
Ovarian Disorders
Anovulation
Clomiphene Citrate hCG hMG Induction + IUI (often done but unjustified)
PRL
Bromocriptine TSS if macroadenoma
POF
?high-dose hMG (not very effective)
Ovarian Disorders
Central amenorrhea
CC first, then hMG Pulsatile GnRH
LPD
Progesterone suppositories during luteal phase CC hCG
Ovarian Matrix
Gonadotropins E2 High WNL Low Treatment
Low ??high-dose hMG, r/o autoimmune diseases WNL CC hCG Low CC first, then hMG
Ovulation Induction
CC
70% induction rate, ~40% pregnancy rate Patients should typically be normoestrogenic Induce menses and start on day 5 With dosages, antiestrogen effects dominate Multifetal rates 5-10% Monitor effects with PK, pelvic exam
hMG (Pergonal)
LH +FSH (also FSH alone = Metrodin) For patients with hypogonadotrophic hypoestrogenism or normal FSH and E2 levels Close monitoring essential, including estradiol levels 60-80% pregnancy rates overall, lower for PCOS patients 10-15% multifetal pregnancy rate
Risks
CC Vasomotor symptoms H/A Ovarian enlargement Multiple gestation NO risk of SAb or malformations
hMG Multiple gestation OHSS (~1%)
Can often be managed as outpatient Diuresis Severe cases fatal if untreated in ICU setting
Fallopian Tubes
Tuboplasty IVF GIFT, ZIFT not options
Corpus
Asherman syndrome
Hysteroscopic lysis of adhesions (scissor) Postop Abx, E2
Cervix
Repeat PK test to rule out inaccurate timing of test If cervicitis Abx If scant mucuslow-dose estrogen Sperm motility issues (? Antisperm ABs)
Steroids? IUI
Peritoneum (Endometriosis)
From a fertility standpoint, excision beats medical management Lysis of adhesions GnRH-a (not a cure and has side effects, expense) Danazol (side effects, cost) Continuous OCPs (poor fertility rates) Chances of pregnancy highest within 6 mos-1 year after treatment
Male Factor
Hypogonadotrophism
hMG GnRH CC, hCG results poor
Varicocoele
Ligation? (no definitive data yet)
Retrograde ejaculation
Ephedrine, imipramine AIH with recovered sperm
Male Factor
Idiopathic oligospermia
No effective treatment ?IVF donor insemination
Unexplained Infertility
5-10% of couples Consider PRL, laparoscopy, other hormonal tests, cultures, ASA testing, SPA if not done Review previous tests for validity Empiric treatment:
Ovulation induction Abx IUI Consider IVF and its variants
Adoption
Summary
Infertility is a common problem Infertility is a disease of couples Evaluation must be thorough, but individualized Treatment is available, including IVF, but can be expensive, invasive, and of limited efficacy in some cases Consultation with a BC/BE reproductive endocrinologist is advisable
Thank you!